Endothelial lipase (EL) and EL-generated lysophosphatidylcholines promote IL-8 expression in endothelial cells

Atherosclerosis

Volumn 214, Issue 2, 2011, Pages 338-344

  Riederer, Monika ^a   Lechleitner, Margarete ^a   Hrzenjak, Andelko ^a   Koefeler, Harald ^a   Desoye, Gernot ^a   Heinemann, Akos ^a   Frank, Saša ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Acyl chain; Adenovirus; Atherosclerosis; Endothelial cells; Endothelial lipase (EL); IL 8; Lysophosphatidylcholine (LPC)

Indexed keywords

BOVINE SERUM ALBUMIN; CALCIUM ION; CHEMOKINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LYSOPHOSPHATIDYLCHOLINE; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; TRIACYLGLYCEROL LIPASE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CALCIUM CELL LEVEL; CHELATION; CONCENTRATION RESPONSE; ENDOTHELIUM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KINETICS; MALE; MOUSE; MUTANT; NONHUMAN; PKA; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RNA SYNTHESIS; SPECIES; TIME;

ANIMALS; CALCIUM; CELLS, CULTURED; CHEMOKINE CXCL2; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-8; KINETICS; LIPASE; LIPOPROTEINS, HDL; LYSOPHOSPHATIDYLCHOLINES; MALE; MICE; MICE, INBRED C57BL; MUTATION; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 79151474913     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.11.007     Document Type: Article

References (30)

1. Jaye M., Lynch K.J., Krawiec J., et al. A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet 1999, 21:424-428.
2. Hirata K., Dichek H.L., Cioffi J.A., et al. Cloning of a unique lipase from endothelial cells extends the lipase gene family. J Biol Chem 1999, 274:14170-14175.
3. McCoy M.G., Sun G.S., Marchadier D., et al. Characterization of the lipolytic activity of endothelial lipase. J Lipid Res 2002, 43:921-929.
4. Strauss J.G., Hayn M., Zechner R., Levak-Frank S., Frank S. Fatty acids liberated from high-density lipoprotein phospholipids by endothelial-derived lipase are incorporated into lipids in HepG2 cells. Biochem J 2003, 371:981-988.
5. Ishida T., Choi S., Kundu R.K., et al. Endothelial lipase is a major determinant of HDL level. J Clin Invest 2003, 111:347-355.
6. Ma K., Cilingiroglu M., Otvos J.D., et al. Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism. Proc Natl Acad Sci U S A 2003, 100:2748-2753.
7. Kojma Y., Hirata K., Ishida T., et al. Endothelial lipase modulates monocyte adhesion to the vessel wall: a potential role in inflammation. J Biol Chem 2004, 279:54032-54038.
8. Ishida T., Choi S.Y., Kundu R.K., et al. Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice. J Biol Chem 2004, 279:45085-45092.
9. Ko K.W., Paul A., Ma K., Li L., Chan L. Endothelial lipase modulates HDL but has no effect on atherosclerosis development in apoE-/- and LDLR-/- mice. J Lipid Res 2005, 46:2586-2594.
10. Gauster M., Rechberger G., Sovic A., et al. Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine. J Lipid Res 2005, 46:1517-1525.
11. Murugesan G., Sandhya Rani M.R., Gerber C.E., et al. Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines. J Mol Cell Cardiol 2003, 35:1375-1384.
12. Rabini R.A., Galassi R., Fumelli P., et al. Redusced Na(+)- K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes 1994, 43:915-919.
13. Chen L., Liang B., Froese D.E., et al. Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients: effect of lysophosphatidylcholine composition on vascular relaxation. J Lipid Res 1997, 38:546-553.
14. Ojala P.J., Hermansson M., Tolvanen M., et al. Identification of alpha-1 acid glycoprotein as a lysophospholipid binding protein: a complementary role to albumin in the scavenging of lysophosphatidylcholine. Biochemistry 2006, 45:14021-14031.
15. Croset M., Brossard N., Polette A., Lagarde M. Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J 2000, 345(Pt 1):61-67.
16. Boisvert W.A. Modulation of atherogenesis by chemokines. Trends Cardiovasc Med 2004, 14:161-165.
17. Hastings N.E., Simmers M.B., McDonald O.G., Wamhoff B.R., Blackman B.R. Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming. Am J Physiol - Cell Physiol 2007, 293:C1824-C1833.
18. Kume N., Cybulsky M.I., Gimbrone M.A. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992, 90:1138-1144.
19. Strauss J.G., Zimmermann R., Hrzenjak A., et al. Endothelial cell-derived lipase mediates uptake and binding of high-density lipoprotein (HDL) particles and the selective uptake of HDL-associated cholesterol esters independent of its enzymic activity. Biochem J 2002, 368:69-79.
20. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
21. Kim Y.L., Im Y.J., Ha N.C., Im D.S. Albumin inhibits cytotoxic activity of lysophosphatidylcholine by direct binding. Prostaglandins Other Lipid Mediat 2007, 83:130-138.
22. Zou Y., Kim C.H., Chung J.H., et al. Upregulation of endothelial adhesion molecules by lysophosphatidylcholine. Involvement of G protein-coupled receptor GPR4. FEBS J 2007, 274:2573-2584.
23. Stentz F.B., Kitabchi A.E. Palmitic acid-induced activation of human T-lymphocytes and aortic endothelial cells with production of insulin receptors, reactive oxygen species, cytokines, and lipid peroxidation. Biochem Biophys Res Commun 2006, 346:721-726.
24. Knipe L., Meli A., Hewlett L., Bierings R., Dempster J., Skehel P., Hannah M.J., Carter T. A revised model for the secretion of tPA and cytokines from cultured endothelial cells. Blood 2010, 116:2183-2191.
25. Yeh M., Gharavi N.M., Choi J., et al. Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway. J Biol Chem 2004, 279:30175-30181.
26. Leik C.E., Walsh S.W. Linoleic acid, but not oleic acid, upregulates production of interleukin-8 by human vascular smooth muscle cells via arachidonic acid metabolites under conditions of oxidative stress. J Soc Gynecol Investig 2005, 12:593-598.
27. Kishimoto S., Kobayashi Y., Oka S., et al. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. J Biochem 2004, 135:517-524.
28. Riederer M., Ojala P., Hrzenjak A., et al. Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production. J Lipid Res 2010, 51:2957-2966.
29. Su Z., Ling Q., Guo Z.G. Effects of lysophosphatidylcholine on bovine aortic endothelial cells in culture. Cardioscience 1995, 6:31-37.
30. Vuong T.D., Braam B., Willekes-Koolschijn N., et al. Hypoalbuminaemia enhances the renal vasoconstrictor effect of lysophosphatidylcholine. Nephrol Dial Transplant 2003, 18:1485-1492.